abstract |
(57) [Summary] [Object] To provide a humanized monoclonal antibody having high specificity for lung cancer and reacting with a cell membrane antigen of lung cancer cells. [Composition] Contract No. F to Institute of Biotechnology, Institute of Industrial Technology Hybridoma ZLG40 having the characteristics of the cell deposited under ERM P-14121, said hybridoma Z A human type monoclonal antibody produced by LG40, a cancer diagnostic agent containing the human type monoclonal antibody or the human type monoclonal antibody fragment as a main component, and a cancer therapeutic agent containing the human type monoclonal antibody or the human type monoclonal antibody fragment as a component is there. |